Novo Nordisk, a global healthcare company with 95 years of innovation and leadership in diabetes care, needed an Internet of Things (IoT = sensors, meters, etc.) platform upon which they could build and operate their current and future digital health offerings aimed at improving diabetes care. In addition to needing an open, device- agnostic platform that could capture data from a variety of continuous blood glucose meters and insulin pens, Novo Nordisk needed a regulated platform built to meet healthcare’s stringent privacy, security, regulatory and quality requirements.
After rigorous evaluation, BrightInsight was selected as it provides a unified IoT platform that enables Novo Nordisk to develop and host digital health devices, apps and algorithms at scale while maintaining compliance with privacy, security, quality and regulatory requirements across the globe.
In this case study, we discuss how BrightInsight enables Novo Nordisk to develop and host digital health devices and apps at scale while maintaining compliance with privacy, security and regulatory requirements across the globe.